Trudy Vanhove

Trudy Vanhove has served on the INSYS Therapeutics Board of Directors since April 2018.

Dr. Vanhove currently serves as the chief medical officer of Surrozen.  Dr. Vanhove previously served as vice president of medical affairs and, subsequently, R&D search and evaluation at Jazz Pharmaceuticals since 2012.  Prior to Jazz Pharmaceuticals, she was vice president, medical affairs at Depomed, Vice President clinical development at NeurogesX and a medical director and project team leader at XOMA.  She began her career as a medical director at Abbott Laboratories in 1996.  Dr. Vanhove earned an MD and a PhD in pharmacology from the Catholic University in Leuven, Belgium.  She completed a fellowship in clinical pharmacology at Stanford University and received an MBA from St. Mary’s College in California.  Dr. Vanhove has authored, or co-authored, several dozens of peer-reviewed articles, and is an inventor on several patents.

Investors

We are a commercial-stage specialty pharmaceutical company that develops and commercializes innovative supportive care and therapeutic products.

 

Investors

We are a commercial-stage specialty pharmaceutical company that develops and commercializes innovative supportive care and therapeutic products.